drugset / Trial / NCT00446017

The Effects of Adrenaline and Milrinone in Patients With Myocardial Dysfunction After CABG

NCT00446017

RandomizedParallel-groupOpen-labelTreatment

Summary

Myocardial dysfunction necessitating inotropic support is a typical complication after on-pump cardiac surgery. This prospective, randomized pilot-study analyses the metabolic and renal effects of the inotropes adrenaline and milrinone in patients needing inotropic support after coronary-artery-bypass-grafting. With respect to data derived from patients with sepsis shock and results from studies using phosphodiesterase-inhibitors prophylactically, the hypothesis is tested that adrenaline may be associated with unwarranted metabolic effects (hyperlactatemia and hyperglycemia) and renal dysfunction.

Timeline

Start
2003-06
Primary completion
2004-08
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified
Subject Milrinone Small molecule

Indications